TransArterial Chemoembolization plus Radiotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TransArterial Chemoembolization plus Radiotherapy, covering 2017-09-18 to 2017-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion [Phase 2, Phase 3]